Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Not Applicable
1 (33.3%)SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction
Not Applicable
Suspended
- Conditions
- DacryocystorhinostomyEpiphora
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Thomas Gardner
- Target Recruit Count
- 50
- Registration Number
- NCT03705000
- Locations
- 🇺🇸
Kellogg Eye Center, 1000 Wall Street, Ann Arbor, Michigan, United States
Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy
Phase 2
Completed
- Conditions
- Diabetic Retinopathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-06-10
- Last Posted Date
- 2018-11-30
- Lead Sponsor
- Thomas Gardner
- Target Recruit Count
- 33
- Registration Number
- NCT00917553
- Locations
- 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
Phase 2
Completed
- Conditions
- Diabetic Retinopathy
- Interventions
- Drug: placebo
- First Posted Date
- 2007-08-06
- Last Posted Date
- 2018-11-02
- Lead Sponsor
- Thomas Gardner
- Target Recruit Count
- 30
- Registration Number
- NCT00511875
- Locations
- 🇺🇸
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
News
No news found